Proyectos
Proiektua TRA24100133
Modeling, unraveling, and beating acquired resistance to BCMA and GPRC5D targeted agents in multiple myeloma.
Finantzatzailea:
INTERNATIONAL MYELOMA SOCIETY (IMS)
date_range
Iraupena 2024(e)ko maiatza-(a)k 01-(e)tik 2025(e)ko apirila-(a)k 30-(e)ra izan da
(12 months)
euro
225.932,00 EUR
Europar-arlokoak.
Deialdi:
International Myeloma Society (IMS) and Paula and Rodger Riney Foundation Translational Research Award 2024
